BackShaanxi Meibang Pharmaceutical Group , Ltd. Overview

Shaanxi Meibang Pharmaceutical Group , Ltd. Receivables

Shaanxi Meibang Pharmaceutical Group , Ltd.'s receivables is $150M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$147.66M
↑ 33.31% YoYΔ $36.89M vs prior year quarter

Peer trimmed avg / median

Loading

Shaanxi Meibang Pharmaceutical Group , Ltd. Receivables History

Loading

Shaanxi Meibang Pharmaceutical Group , Ltd. vs. peers: Receivables Comparison

Loading

Shaanxi Meibang Pharmaceutical Group , Ltd. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Shaanxi Meibang Pharmaceutical Group , Ltd. (605033.SS) FAQ

As of the most recent data (September 2026), 605033.SS shows a receivables of $150M. That compares with $110M in the prior-year period — up 33.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 605033.SS's receivables is now $150M (was $110M) — a 33.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Shaanxi Meibang Pharmaceutical Group , Ltd. is outperforming or lagging.

Tracking 605033.SS's receivables over time shows whether Shaanxi Meibang Pharmaceutical Group , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $150M That compares with $110M in the prior-year period — up 33.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Shaanxi Meibang Pharmaceutical Group , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $150M) with ownership activity and broader fundamentals.